Sign Up to like & get
recommendations!
2
Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms23147669
Abstract: Efavirenz (EFV), an FDA-approved anti-HIV drug, has off-target binding to CYP46A1, the CNS enzyme which converts cholesterol to 24-hydroxycholesterol. At small doses, EFV allosterically activates CYP46A1 in mice and humans and mitigates some of the…
read more here.
Keywords:
5xfad mice;
increased acetylcholine;
cyp46a1;
brain ... See more keywords